SCHEMBL6003176

SCHEMBL6003176

CCOCC(=O)N(c1ccc(CF)cc1)C1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ MITF O75030 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ PAX8 Q06710 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ TRPM8 Q7Z2W7 3/20 0.43
▸ MLYCD O95822 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ ENPP2 Q13822 1/20 0.41
▸ CASP6 P55212 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ OPRM1 P35372 2/20 0.38
▸ SIGMAR1 Q99720 1/20 0.38
▸ TACR1 P25103 1/20 0.38
▸ AGTR2 P50052 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2094200 0.88 MEN1 (0.48) MEN1KMT2AKDM4ENPC1MITF
SCHEMBL2094195 0.85 MEN1 (0.48) MEN1KMT2AKDM4ENPC1MITF
SCHEMBL2094924 0.82 MEN1 (0.52) MEN1KMT2AKDM4ENPC1MITF
SCHEMBL2094921 0.82 MEN1 (0.52) MEN1KMT2AKDM4ENPC1MITF
SCHEMBL2096223 0.81 OPRM1 (0.41) MEN1KMT2AKDM4ENPC1MITF
SCHEMBL6003174 0.81 TRPM8 (0.43) MEN1KMT2AKDM4ENPC1MITF
SCHEMBL2094198 0.79 TRPM8 (0.46) MEN1KMT2AKDM4ENPC1MITF
SCHEMBL2096218 0.78 TACR1 (0.40) MEN1KMT2AKDM4ENPC1MITF
SCHEMBL9260624 0.77 KDM4E (0.59) MEN1KMT2AKDM4ENPC1MITF
SCHEMBL2097750 0.74 MEN1 (0.42) MEN1KMT2AKDM4ENPC1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 — — EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 — — WO disclosed
Send feedback